Leadership duties shift within CDER

01/31/2012 | Pharmalot.com

Bob Temple is giving up his post as acting director of the Office of Drug Evaluation I at the FDA's Center for Drug Evaluation and Research and will be replaced by Ellis Unger, the office's deputy director. The change will allow Temple to devote more time to his duties as deputy director for clinical science, according to CDER Director Janet Woodcock.

View Full Article in:

Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ